Worth reading
72In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
11840000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Report on the exercise status of the 16th Series of Stock Acquisition Rights with an exercise price adjustment clause through a third-party allotment
発行・処分する株式数11,840,000Shares
11,840,000 new shares
発行済株式総数
9.0% (exercise ratio subject to exercise restrictions)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥39.6. For details of the exercise price adjustment clause, the document refers to the issuance disclosure dated 27 March 2026.
Number of Stock Acquisition Rights
Total issued: 210,000 rights; exercised since the beginning of the month: 118,400 rights; currently unexercised: 91,600 rights
Most recent equity financing
27 March 2026: Issuance through a third-party allotment of the 16th Series of Stock Acquisition Rights with an exercise price adjustment clause, the 17th through 19th Series of Stock Acquisition Rights, and the 2nd unsecured ordinary corporate bonds, and execution of a purchase agreement for the Stock Acquisition Rights
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the exercise status of the 16th Series of Stock Acquisition Rights with an exercise price adjustment clause through a third-party allotment |
| Number of shares to be issued or disposed of | 11,840,000 new shares |
| Dilution Rate | 9.0% (exercise ratio subject to exercise restrictions) |
| Total number of issued shares | 131,420,693 shares → Not disclosed |
| Exercise price | ¥39.6. For details of the exercise price adjustment clause, the document refers to the issuance disclosure dated 27 March 2026. |
| Number of Stock Acquisition Rights | Total issued: 210,000 rights; exercised since the beginning of the month: 118,400 rights; currently unexercised: 91,600 rights |
| Most recent equity financing | 27 March 2026: Issuance through a third-party allotment of the 16th Series of Stock Acquisition Rights with an exercise price adjustment clause, the 17th through 19th Series of Stock Acquisition Rights, and the 2nd unsecured ordinary corporate bonds, and execution of a purchase agreement for the Stock Acquisition Rights |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The document does not explain any reason other than the bulk exercise.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.